Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT.

Diabetologia. 2012 May;55(5):1265-72. doi: 10.1007/s00125-011-2418-8. Epub 2012 Jan 5.

2.

To test, or not to test: time for a MODY calculator?

Njølstad PR, Molven A.

Diabetologia. 2012 May;55(5):1231-4. doi: 10.1007/s00125-012-2514-4. Epub 2012 Mar 2.

PMID:
22382521
3.

Detecting intentional insulin omission for weight loss in girls with type 1 diabetes mellitus.

Pinhas-Hamiel O, Hamiel U, Greenfield Y, Boyko V, Graph-Barel C, Rachmiel M, Lerner-Geva L, Reichman B.

Int J Eat Disord. 2013 Dec;46(8):819-25. doi: 10.1002/eat.22138. Epub 2013 May 15.

PMID:
23674378
4.

Comorbidity and glycemic control in patients with type 2 diabetes.

El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2001 May 28;161(10):1295-300.

PMID:
11371257
5.

Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.

Maltoni G, Zucchini S, Scipione M, Mantovani V, Salardi S, Cicognani A.

Pediatr Diabetes. 2012 Mar;13(2):208-12. doi: 10.1111/j.1399-5448.2011.00788.x. Epub 2011 Jun 23.

PMID:
21696527
6.

Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index.

Thomas C, Hyppönen E, Power C.

Arch Intern Med. 2006 Mar 27;166(6):682-8.

PMID:
16567609
7.

Serum adiponectin helps to differentiate type 1 and type 2 diabetes among young Asian Indians.

Gokulakrishnan K, Aravindhan V, Amutha A, Abhijit S, Ranjani H, Anjana RM, Unnikrishnan R, Miranda P, Narayan KM, Mohan V.

Diabetes Technol Ther. 2013 Aug;15(8):696-702. doi: 10.1089/dia.2012.0306. Epub 2013 Jul 31.

8.

Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.

Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW; DPV-Wiss Initiative of the German Working Group for Paediatric Diabetology and.

Diabet Med. 2009 May;26(5):466-73. doi: 10.1111/j.1464-5491.2009.02720.x.

PMID:
19646184
9.

Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.

Pihoker C, Gilliam LK, Ellard S, Dabelea D, Davis C, Dolan LM, Greenbaum CJ, Imperatore G, Lawrence JM, Marcovina SM, Mayer-Davis E, Rodriguez BL, Steck AK, Williams DE, Hattersley AT; SEARCH for Diabetes in Youth Study Group.

J Clin Endocrinol Metab. 2013 Oct;98(10):4055-62. doi: 10.1210/jc.2013-1279. Epub 2013 Jun 14.

10.

High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone analysis.

Bellanné-Chantelot C, Coste J, Ciangura C, Fonfrède M, Saint-Martin C, Bouché C, Sonnet E, Valéro R, Lévy DJ, Dubois-Laforgue D, Timsit J; Monogenic Diabetes Study Group of the Société Francophone du Diabète (SFD).

Diabetes Metab. 2016 Feb;42(1):33-7. doi: 10.1016/j.diabet.2015.02.001. Epub 2015 Mar 6.

PMID:
25753245
11.

Professional continuous glucose monitoring for the identification of type 1 diabetes mellitus among subjects with insulin therapy.

Chen YC, Huang YY, Li HY, Liu SW, Hsieh SH, Lin CH.

Medicine (Baltimore). 2015 Jan;94(3):e421. doi: 10.1097/MD.0000000000000421.

12.

Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

Besser RE, Shields BM, Hammersley SE, Colclough K, McDonald TJ, Gray Z, Heywood JJ, Barrett TG, Hattersley AT.

Pediatr Diabetes. 2013 May;14(3):181-8. doi: 10.1111/pedi.12008. Epub 2013 Jan 4.

PMID:
23289766
13.

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.

Mughal SA, Park R, Nowak N, Gloyn AL, Karpe F, Matile H, Malecki MT, McCarthy MI, Stoffel M, Owen KR.

Diabet Med. 2013 Feb;30(2):246-50. doi: 10.1111/dme.12066.

14.

HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.

Bennett CM, Guo M, Dharmage SC.

Diabet Med. 2007 Apr;24(4):333-43. Epub 2007 Mar 15. Review. Erratum in: Diabet Med. 2007 Sep;24(9):1054.

PMID:
17367307
15.

Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.

Morgan CL, Evans M, Toft AD, Jenkins-Jones S, Poole CD, Currie CJ.

Clin Ther. 2011 Jan;33(1):27-35. doi: 10.1016/j.clinthera.2011.01.023. Erratum in: Clin Ther. 2011 Mar;33(3):391.

PMID:
21397771
16.

Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.

Petitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, Imperatore G, Marcovina S, Pihoker C, Standiford D, Waitzfelder B, Mayer-Davis E; SEARCH for Diabetes in Youth Study Group.

J Pediatr. 2009 Nov;155(5):668-72.e1-3. doi: 10.1016/j.jpeds.2009.05.025. Epub 2009 Jul 29.

17.

HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.

Bhowmik B, Diep LM, Munir SB, Rahman M, Wright E, Mahmood S, Afsana F, Ahmed T, Khan AK, Hussain A.

Diabet Med. 2013 Mar;30(3):e70-7. doi: 10.1111/dme.12088. Erratum in: Diabet Med. 2016 Feb;33(2):271.

PMID:
23199158
18.

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.

Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.

Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.

PMID:
20536498
19.

HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.

Fendler W, Borowiec M, Antosik K, Szadkowska A, Deja G, Jarosz-Chobot P, Mysliwiec M, Wyka K, Pietrzak I, Skupien J, Malecki MT, Mlynarski W.

Clin Endocrinol (Oxf). 2011 Sep;75(3):321-7. doi: 10.1111/j.1365-2265.2011.04052.x.

PMID:
21521320
20.

Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus.

Botana López MA, López Ratón M, Tomé MA, Fernández Mariño A, Mato Mato JA, Rego Iraeta A, Pérez Fernández R, Cadarso Suárez C.

Endocrinol Nutr. 2012 Oct;59(8):496-504. doi: 10.1016/j.endonu.2012.06.001. Epub 2012 Aug 1.

PMID:
22857908

Supplemental Content

Support Center